RankAlpha logo
Back to Rankings

OMER

OmerosD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
OMER vs peer average
24/100
OMER vs. peer average (D vs. B)
Grade spread
A 2 · B 4 · C 2 · D 2
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

NTLA is the first available peer comparator.

Less direct operationally, but a useful small-cap biotech comp for milestone sensitivity, valuation swings around pipeline milestones and financing-risk perception.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerNTLAIntellia Therapeutics
OMER
Omeros
NTLA
Intellia Therapeutics
Grade
D
D
Momentum
35
17
Value
41
41
Sentiment
61
65
Setup Bias
Net Bullish
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs NTLA

OMER / NTLA
Grade Position
Below peers
OMER vs. peer average (D vs. B)
24/100
Momentum
35
OMER
Value
41
OMER
Sentiment
61
NTLA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OMER
1
NTLA
NTLA
D
40/100
Even
2
PCRX
PCRX
B
80/100
-2
3
REGN
REGN
C
60/100
-1
4
VOR
Vor Biopharma Inc Common
D
40/100
Even
5
BIOA
BioAge Labs Inc Common
N/A
-
-
NTLA is the first peer returned for this comparison set.